The early bird
How high school student Allison Bien found a place in science
C is for Vitamin C—a key ingredient for immune cell function
Harnessing the combined power of Vitamin C and TET proteins may give scientists a leg up in treating autoimmune diseases
Preparing T cells for the long haul
New LJI research could keep cancer-fighting T cells from burning out before the job is done
Sydney Ramirez investigates a lingering COVID-19 question
New A.P. Giannini Foundation Fellowship opens the door to an in-depth look at SARS-CoV-2 infections
Can we stretch existing Covid vaccines to inoculate more people? Experts are divided
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
A biochemist takes on Lassa virus
LJI Postdoctoral Fellow Adrian Enriquez wins funding to study how antibodies fight the deadly Lassa virus.
Hard-working enzyme keeps immune cells in line
LJI scientists develop new tool for understanding enzymatic activity linked to blood cancers and heart disease
Many cancer patients may need a sequential one-two punch of immunotherapies
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy
Sonia Sharma zeros in on metabolites
Cancer immunotherapies may have a better chance of working if scientists can reintroduce a missing metabolite